Drive Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,859
Closed -$266K 384
2025
Q2
$266K Sell
3,859
-1,348
-26% -$91.7K 0.06% 254
2025
Q1
$367K Sell
5,207
-1,492
-22% -$123K 0.09% 182
2024
Q4
$576K Sell
6,699
-2,645
-28% -$286K 0.14% 116
2024
Q3
$1.11M Sell
9,344
-94
-1% -$12.5K 0.29% 66
2024
Q2
$1.35M Sell
9,438
-52
-0.5% -$6.89K 0.36% 53
2024
Q1
$1.23M Sell
9,490
-324
-3% -$38.6K 0.34% 58
2023
Q4
$1.02M Buy
9,814
+71
+0.7% +$7.02K 0.33% 64
2023
Q3
$886K Buy
9,743
+491
+5% +$43.3K 0.32% 66
2023
Q2
$748K Buy
9,252
+52
+0.6% +$4.25K 0.28% 77
2023
Q1
$738K Sell
9,200
-1,678
-15% -$119K 0.31% 82
2022
Q4
$736K Buy
10,878
+1,768
+19% +$104K 0.37% 64
2022
Q3
$454K Buy
9,110
+798
+10% +$42.7K 0.43% 62
2022
Q2
$463K Buy
8,312
+206
+3% +$11.4K 0.42% 64
2022
Q1
$454K Buy
8,106
+808
+11% +$41.5K 0.38% 73
2021
Q4
$409K Buy
+7,298
New +$395K 0.36% 80

Other funds holding NVO

Drive Wealth Management's NVO Position: Q3 2025 in Review

Drive Wealth Management sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 3,859 shares — an estimated $266K sold.

Drive Wealth Management first reported a position in NVO in Q4 2021 and held it in 15 quarters. The position peaked at $1.35M in Q2 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Drive Wealth Management reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Drive Wealth Management sold 3,859 Novo Nordisk shares in Q3 2025, an estimated $266K.
  • Drive Wealth Management first reported a position in Novo Nordisk in Q4 2021 and held it in 15 quarters.
  • Drive Wealth Management's Novo Nordisk position peaked at $1.35M in Q2 2024.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Drive Wealth Management's 13F filing for Q3 2025, filed 31 Oct 2025.